Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) National survey on the treatment of cholelitiasis in Spain during the initial pe...
Journal Information
Vol. 99. Issue 5.
Pages 346-353 (May 2021)
Share
Share
Download PDF
More article options
ePub
Visits
1
Vol. 99. Issue 5.
Pages 346-353 (May 2021)
Original article
DOI: 10.1016/j.cireng.2021.04.019
National survey on the treatment of cholelitiasis in Spain during the initial period of the COVID-19 pandemic
Encuesta nacional sobre el tratamiento de la colelitiasis en España durante la fase inicial de la pandemia por COVID-19
Visits
...
Benedetto Ielpoa,
Corresponding author
ielpo.b@gmail.com

Corresponding author.
, Mikel Prietob, Irene Ortegac, José María Balibread, Inés Rubio-Péreze, Montse Juvanyf, Miguel Ángel Gómez-Bravog, José Manuel Ramiah
a Unidad de Cirugia Hepatobiliopancreática, Hospital Universitario del Mar, Barcelona, Spain
b Unidad Hepatobiliar, Transplante Hepático y Retroperitoneo, Hospital Universitario Cruces, Bilbao, Spain
c Sección de Cirugía Hepatobiliopancreática, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid. Universidad Europea de Madrid, Madrid, Spain
d Servicio de Cirugía Gastrointestinal (ICMDiM), Hospital Clínic de Barcelona, Universitat de Barcelona. Sección de Infección Quirúrgica, AEC, Barcelona, Spain
e Servicio de Cirugía General, Hospital Universitario La Paz, Madrid, Spain
f Servicio de Cirugía General, Hospital General de Granollers, Universitat Internacional de Catalunya, Barcelona, Spain
g Unidad de Cirugía HPB y Trasplantes, Hospital Universitario Virgen del Rocío, Sevilla, Spain
h Servicio de Cirugía, Hospital Universitario de Guadalajara, Guadalajara, Spain
Related content
Cir Esp. 2021;99:395-610.1016/j.cireng.2021.02.027
Pedro López Morales, Miguel Ruiz Marín, Clara Giménez Francés, Antonio Albarracín Marín-Blázquez
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Tables (3)
Table 1. Data of the surgeons who responded to this survey.
Table 2. Data about the hospitals, organization and management of cholelithiasis.
Table 3. Changes in treatment of acute cholecystitis before and during the COVID-19 pandemic.
Show moreShow less
Additional material (1)
Abstract
Introduction

The extraordinary impact of COVID-19 pandemic on Spanish hospitals has led to a redistribution of resources for the treatment of these patients, with a decreased capacity of care for other common diseases. The aim of the present study is to analyse how this situation has affected the treatment of cholecystitis and cholelythiasis.

Methods

It is a descriptive national study after online voluntary distribution of a specific questionnaire with Google Drive™ to members of the Spanish Association of Surgeons (AEC).

Results

We received 153 answers (one per hospital). Elective cholecystectomies have been cancelled in 96.7% of centres. Conservative treatment for acute cholecystitis has been selected in 90% (previously 18%), and if operated, 95% have been performed laparoscopically. Globally, only 49% perform preoperative diagnostic tests for SARS-CoV-2, and 58.5% recognize there have been cases confirmed postoperatively after other surgeries, with worse surgical outcomes in 54%.

Conclusions

This survey shows that most of the Spanish centers are following the surgical societies suggestions during the pandemic. However, some data requires to be taken into account for the next phase of the pandemic.

Keywords:
Cholelithiasis
Acute cholecystitis
COVID-19
SARS-CoV-2
Survey
Resumen
Introducción

La pandemia COVID-19 ha tenido una repercusión extraordinaria sobre los hospitales españoles, que han reorganizado sus recursos para tratar a estos pacientes, limitando su capacidad de atender otras patologías frecuentes. El presente estudio analiza la repercusión sobre el tratamiento de la colelitiasis y la colecistitis aguda.

Métodos

Se ha realizado un estudio nacional descriptivo mediante una encuesta online voluntaria, realizada en Google Drive™, distribuida por correo electrónico desde la Asociación Española de Cirujanos (AEC) a todos los cirujanos miembros.

Resultados

Se han recibido 153 encuestas (una por centro). El 96,7% de ellos han suspendido las colecistectomías electivas. El tratamiento conservador de la colecistitis aguda no complicada se ha realizado en un 90% de los casos (siendo previamente del 18%) y, en las colecistitis intervenidas, el 95% ha optado por el abordaje laparoscópico. Un 49% realiza algún test preoperatorio para SARS-CoV-2, y el 57% comunica haber tenido casos de confirmación postoperatoria tras alguna intervención, con peor evolución postoperatoria en el 54%.

Conclusiones

Esta encuesta revela que la mayoría de los centros están siguiendo las recomendaciones de las sociedades quirúrgicas durante la pandemia por COVID-19. Sin embargo, se observan algunos datos que precisan ser tenidos en cuenta en las fases sucesivas de la pandemia.

Palabras clave:
Colelitiasis
Colecistitis aguda
COVID-19
SARS-CoV-2
Encuesta

Article

These are the options to access the full texts of the publication Cirugía Española (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Cirugía Española (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
Supplemental materials
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos